Lucie Turcotte, MD, MPH

Dr. Lucie Turcotte is an Assistant Professor of Pediatrics in the Division of Hematology/Oncology at the University of Minnesota. She is currently working on an NIH-funded study aimed at understanding treatment decision-making for female survivors of childhood cancer who develop secondary breast cancer. She hopes to better understand how treatments are chosen, how therapies are tolerated, and how survival compares to women with primary breast cancer.

Dr. Turcotte received her MPH in Maternal and Child Health from the University of Minnesota School of Public Health in 2005 and her medical degree from the University of Minnesota Medical School in 2007. She completed her residency in Pediatrics in 2010 at Seattle Children’s Hospital in Seattle, WA, and completed her fellowship in Pediatric Hematology, Oncology, and Bone Marrow Transplant in 2013 at the University of Minnesota Masonic Children’s Hospital. During her fellowship, she also completed coursework for a Master of Science in Clinical Research. She's chosen to stay at the University of Minnesota because it is a pioneer and leader in the field of cancer survivorship research.

Dr. Turcotte’s research has focused on second malignancies and short- and long-term outcomes in pediatric cancer survivors. She has specific clinical interest in childhood leukemias and lymphomas, as well as in histiocytic disorders. She has been named a Top Doctor through Minnesota Monthly magazine, awarded Clinical/Translational Paper of the Year in the Department of Pediatrics in 2017 and 2019, and was the recipient of the Children's Cancer Research Fund Butterfly Award in 2019.

• Minnesota Monthly “Top Doctors” (2016-2019, 2021)
• Clinical/Translational Paper of the Year (Assistant Professor), Department of Pediatrics, University of Minnesota (2018)
• Minneapolis - St. Paul “Top Doctors, Rising Star Edition” (2015-2017)
• Gold Humanism Honor Society (2006)
• Minnesota Medical Foundation Medical Student Achievement Award (2007)

• Turcotte LM, Liu Q, Yasui Y, Arnold MA, Hammond S, Howell RM, Smith SA, Weathers RE, Henderson TO, Gibson TM, Leisenring W, Armstrong GT, Robison LL, Neglia JP (2017). Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015. JAMA Pediatrics 317, 814-824.